Drawing for GREENKISS

USPTO serial 86643913

GREENKISS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MILTON, PRISCILLA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GREENKISS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory P. Gulia

Gregory P. Gulia Duane Morris LLP1540 BroadwayNew York, NY 10036-4086UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Alcohol for medicinal purposes; Alcohol for pharmaceutical purposes; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal alcohol; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Plant extracts for medical, veterinary and pharmaceutical purposesACTIVE—
010Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human bodyACTIVE—
029Nut and seed-based snack bars; Organic nut and seed-based snack bars; Processed edible seeds; Seed butters; Trail mix consisting primarily of processed nuts, seeds, dried fruit and also including chocolateACTIVE—
031Agricultural seeds; Plant seeds; Seeds for agricultural purposes; Seeds for flowers; Seeds for fruit and vegetables; Seeds for horticultural purposes; Seeds for planting; Unprocessed edible seeds; Unprocessed oil seeds; Vegetable seeds for plantingACTIVE—
032Non-carbonated, non-alcoholic frozen flavored beveragesACTIVE—
035Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through print, audio, video, digital and on-line medium; Advertising services, namely, promoting the brands, goods and services of others; Brand concept and brand development services for corporate and individual clients; Brand concept and brand development services for corporate clients; Brand evaluation services; Brand positioning services; Marketing and branding services, namely, providing customized communication programs to obtain consumer insights and develop branding strategies; On-line customer-based social media brand marketing services; Promoting, advertising and marketing of the brands, products, services and online websites of individuals, businesses and nonprofit organizationsACTIVE—
042Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and developmentACTIVE—
044Providing an on-line database featuring information regarding plant and seed collections for agricultural purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 21, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 21, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 19, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 4, 2016ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 17, 2016CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 17, 2016COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 7, 2016CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jan 6, 2016APETASSIGNED TO PETITION STAFF—
Dec 16, 2015EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 2, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 20, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 9, 2015DOCKASSIGNED TO EXAMINER—
Jun 3, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 1, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance